Last reviewed · How we verify
Ephedrine-P
At a glance
| Generic name | Ephedrine-P |
|---|---|
| Also known as | vasopressor |
| Sponsor | Dalian Municipal Central Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia (PHASE4)
- Ephedrine Versus Ondansetron During Cesarean Delivery (PHASE4)
- Ephedrine and Phenylephrine for Spinal Hypotension (PHASE2, PHASE3)
- Influence of a Bolus Administration of Ephedrine and Phenylephrine on the Spinal Oxygen Saturation, Measured With NIRS. (PHASE4)
- Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |